SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-000651
Filing Date
2023-01-05
Accepted
2023-01-05 16:15:25
Documents
15
Period of Report
2023-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10046334_8k.htm   iXBRL 8-K 30051
2 EXHIBIT 99.1 brhc10046334_ex99-1.htm EX-99.1 26558
7 image0.jpg GRAPHIC 4021
  Complete submission text file 0001140361-23-000651.txt   245866

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bngo-20230105.xsd EX-101.SCH 4328
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20230105_def.xml EX-101.DEF 17539
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20230105_lab.xml EX-101.LAB 27037
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20230105_pre.xml EX-101.PRE 19724
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10046334_8k_htm.xml XML 6220
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 23511470
SIC: 3826 Laboratory Analytical Instruments